Literature DB >> 12220213

Differing pathways of lower airway colonization and infection according to mode of ventilation (endotracheal vs tracheotomy).

Pradeep Morar1, Vivian Singh, Zvoru Makura, Andrew Jones, Paul Baines, Andrew Selby, Richard Sarginson, Julie Hughes, Rick van Saene.   

Abstract

OBJECTIVES: To determine whether the pathogenesis of lower airway colonization and infection was endogenous (via the oropharynx) or exogenous (via the endotracheal tube or tracheotomy) during the 2 modes of ventilation in the same subset of children requiring long-term ventilation.
DESIGN: Prospective, observational cohort study.
SETTING: A pediatric intensive care unit and a respiratory ward. PATIENTS: Consecutive admissions between September 1, 1993, and August 30, 1998.
MEASUREMENTS AND MAIN RESULTS: Cultures were obtained simultaneously from the oropharynx and tracheobronchial tree on admission to the pediatric intensive care unit, at placement of the tracheotomy, and afterward twice weekly. Forty-five patients were studied. Lower airways were always sterile in 6 children, 39 children (87%) developed a total of 82 episodes of colonization, and 17 (38%) progressed to 25 episodes of infection. The number of infected children was halved once they had a tracheotomy (7 children [16%]). Of the 107 episodes of colonization and infection, 41 and 66 occurred during endotracheal ventilation and via a tracheotomy, respectively. Primary endogenous episodes of colonization and infection due to bacteria present in the admission flora in the pediatric intensive care unit were significantly more common with endotracheal ventilation than during ventilation via a tracheotomy (31/41 [76%] vs 36/66 [55%]; P =.03). Secondary endogenous and exogenous episodes of colonization and infection due to bacteria associated with the respiratory ward were significantly more frequent when ventilation was continued through a tracheotomy than during endotracheal ventilation (30/66 [45%] vs 10/41 [24%]; P =.02).
CONCLUSIONS: Surveillance samples allow the distinction between primary endogenous ("imported" bacteria) from secondary endogenous and exogenous ("nosocomial" microorganisms) colonization and infection. This classification permits the development of preventive strategies to control both endogenous and exogenous pathways.

Entities:  

Mesh:

Year:  2002        PMID: 12220213     DOI: 10.1001/archotol.128.9.1061

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  6 in total

Review 1.  All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth.

Authors:  Hendrick K F van Saene; Andy J Petros; Graham Ramsay; Derrick Baxby
Journal:  Intensive Care Med       Date:  2003-04-10       Impact factor: 17.440

2.  Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit: a 9-year prospective study.

Authors:  Enrique Cerdá; Ana Abella; Miguel A de la Cal; José A Lorente; Paloma García-Hierro; Hendrick K F van Saene; Inmaculada Alía; Ainhoa Aranguren
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

Review 3.  Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth.

Authors:  Luciano Silvestri; Miguel A de la Cal; Hendrick K F van Saene
Journal:  Intensive Care Med       Date:  2012-09-22       Impact factor: 17.440

4.  Effects of nursing intervention on lung infection prevention in patients with tracheotomy.

Authors:  Hua Li; Xiao-Hong Mao
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 5.  Diagnosis, management, and outcomes of pediatric tracheostomy-associated infections: A scoping review.

Authors:  John M Morrison; Amir Hassan; Lynn Kysh; Robert A Dudas; Christopher J Russell
Journal:  Pediatr Pulmonol       Date:  2022-03-09

6.  Development of Chronic Pseudomonas aeruginosa-Positive Respiratory Cultures in Children with Tracheostomy.

Authors:  Christopher J Russell; Tamara D Simon; Michael N Neely
Journal:  Lung       Date:  2019-10-31       Impact factor: 3.777

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.